SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001398432-18-000131
Filing Date
2018-11-19
Accepted
2018-11-19 16:09:59
Documents
70
Period of Report
2018-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q a14177.htm 10-Q 341502
2 SECTION 302 CERTIFICATION EXHIBIT exh31_1.htm EX-31.1 10074
3 SECTION 906 CERTIFICATION EXHIBIT exh32_1.htm EX-32.1 3233
  Complete submission text file 0001398432-18-000131.txt   4976744

Data Files

Seq Description Document Type Size
4 nphc-20180930.xml EX-101.INS 675049
5 nphc-20180930.xsd EX-101.SCH 73105
6 nphc-20180930_cal.xml EX-101.CAL 31332
7 nphc-20180930_def.xml EX-101.DEF 326376
8 nphc-20180930_lab.xml EX-101.LAB 383520
9 nphc-20180930_pre.xml EX-101.PRE 327904
Mailing Address 12538 W. ATLANTIC BLVD. CORAL SPRINGS FL 33071
Business Address 12538 W. ATLANTIC BLVD. CORAL SPRINGS FL 33071 (954) 509-0911
NUTRA PHARMA CORP (Filer) CIK: 0001119643 (see all company filings)

IRS No.: 912021600 | State of Incorp.: CA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-32141 | Film No.: 181192588
SIC: 2833 Medicinal Chemicals & Botanical Products
Assistant Director 1